Xtx Topco LTD Galera Therapeutics, Inc. Transaction History

Xtx Topco LTD

  • $1.3 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$0.08 - $0.23 $2,149 - $6,179
26,867 Added 106.42%
52,113 $7,000
Q1 2024

May 13, 2024
SELL
$0.14 - $0.27 $2,027 - $3,909
-14,480 Reduced 36.45%
25,246 $3,000
Q4 2023

Feb 13, 2024
BUY
$0.09 - $0.27 $3,575 - $10,726
39,726 New
39,726 $5,000
Q2 2023

Aug 14, 2023
BUY
$2.5 - $3.42 $133,730 - $182,942
53,492 New
53,492 $166,000
Q1 2022

May 13, 2022
SELL
$2.01 - $4.19 $27,132 - $56,560
-13,499 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$1.27 - $8.28 $17,143 - $111,771
13,499 New
13,499 $62,000

Others Institutions Holding GRTX

# of Institutions
2
Shares Held
909K
Call Options Held
0
Put Options Held
0
View Full List

About Galera Therapeutics, Inc.

GRTX Quotes by TradingView
  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $1.07M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email